Trials / Completed
CompletedNCT06193109
The Prognostic Impact of Right Ventricular Systolic Dysfunction on the Survival of Patients With Sepsis and Septic Shock
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (actual)
- Sponsor
- Burapha University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study sought to evaluate the association of right ventricular systolic dysfunction and 28-day in-hospital mortality in patients with sepsis and septic shock. Prospective cohort study of adult patients admitted at Burapha university hospital from October 1, 2022 through June 30, 2023 for sepsis and septic shock, who had an echocardiogram within 72 hours after admission for evaluating right ventricular systolic function. Right ventricular systolic dysfunction was defned by the American Society of Echocardiography criteria. Outcomes included 28-day in-hospital mortality, maximal blood lactate, length of intensive care unit(ICU) stay and duration of mechanical ventilation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | — | the patients with sepsis and septic shock were performed echocardiography for detecting right ventricular systolic function |
Timeline
- Start date
- 2022-10-01
- Primary completion
- 2023-06-30
- Completion
- 2023-07-30
- First posted
- 2024-01-05
- Last updated
- 2024-01-05
Locations
1 site across 1 country: Thailand
Source: ClinicalTrials.gov record NCT06193109. Inclusion in this directory is not an endorsement.